Q/C TECHNOLOGIES, INC. — Director's Dealing 2021

Apr 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MyMD Pharmaceuticals, Inc. (MYMD)
CIK: 0001321834
Period of Report: 2021-04-16

Reporting Person: Uzonwanne Jude (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-16	Stock Option (Right to Buy)	$2.5913	A	115770	Acquired	2023-04-16	Common Stock (115770)	Direct

Footnotes

F1: Received in exchange for a stock option to acquire 300,000 shares of common stock of a private company formerly known as "MyMD Pharmaceuticals, Inc." (the "Former Entity") at $1.00 per share in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share.

F2: The shares underlying this stock option shall vest according to the following schedule: 50% on October 26, 2021 and 50% on October 26, 2022.